Mersana Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Mersana Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Mersana Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Mersana Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $37k | 16k | 2.32 |
| 2023-09-30 | $2.2k | 1.7k | 1.27 |
| 2023-03-31 | $2.1M | 499k | 4.11 |
| 2022-12-31 | $1.6M | 274k | 5.86 |
| 2022-09-30 | $1.3M | 197k | 6.76 |
| 2021-12-31 | $1.4M | 227k | 6.22 |
| 2021-03-31 | $3.7M | 230k | 16.18 |
| 2020-12-31 | $352k | 13k | 26.64 |
| 2020-09-30 | $72k | 3.8k | 18.73 |
| 2020-06-30 | $611k | 26k | 23.41 |
| 2020-03-31 | $59k | 10k | 5.81 |
| 2019-12-31 | $41k | 7.2k | 5.70 |
| 2019-09-30 | $4.0k | 2.3k | 1.72 |
| 2019-06-30 | $37k | 9.2k | 4.00 |
| 2019-03-31 | $17k | 3.4k | 5.04 |
| 2018-12-31 | $14k | 3.3k | 4.23 |
| 2018-09-30 | $28k | 2.8k | 9.94 |
| 2018-03-31 | $1.0k | 56 | 17.86 |
| 2017-12-31 | $21k | 1.3k | 16.05 |
| 2017-09-30 | $325k | 19k | 17.28 |